Belleau Labs
Back to companies

Persist AI

Seed / Series A

defense-autonomy · Seed

Seed Signal Score
8/25
Team Strength
2/5
Validation Depth
2/5
Novelty
1/5
Market Timing
1/5
Capital Efficiency
2/5

Description

Developing long-lasting drug formulations 50% faster

Validation Signals

yc batch

Score Rationale

Persist AI is classified as defense-autonomy but the stated mission (long-lasting drug formulations) has no visible connection to defense, autonomous systems, or DoD priorities—this appears to be a data mislabeling or the company description is incomplete/inaccurate. YC Winter 2023 acceptance provides some credibility, but without named founders, technical details, customer traction, or evidence of defense application, validation remains minimal and market fit is unclear.
Back to all companies